Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species.
about
Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the ShipEvaluation of an automated rapid diagnostic assay for detection of Gram-negative bacteria and their drug-resistance genes in positive blood culturesImproved sensitivity for molecular detection of bacterial and Candida infections in bloodEvaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood culturesIndividualized Approaches Are Needed for Optimized Blood Cultures.Implementation of rapid diagnostics with antimicrobial stewardship.A Stewardship Approach To Optimize Antimicrobial Therapy through Use of a Rapid Microarray Assay on Blood Cultures Positive for Gram-Negative Bacteria.Effect of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Alone versus MALDI-TOF MS Combined with Real-Time Antimicrobial Stewardship Interventions on Time to Optimal Antimicrobial Therapy in Patients withControversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials.Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.Clinical Impact of Laboratory Implementation of Verigene BC-GN Microarray-Based Assay for Detection of Gram-Negative Bacteria in Positive Blood Cultures.Emerging technologies for rapid identification of bloodstream pathogens.Review of rapid diagnostic tests used by antimicrobial stewardship programs.Emerging commercial molecular tests for the diagnosis of bloodstream infection.Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomes.Molecular antibiogram in diagnostic clinical microbiology: advantages and challenges.The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis.Experience With Rapid Microarray-Based Diagnostic Technology and Antimicrobial Stewardship for Patients With Gram-Positive Bacteremia.Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship ProgramsEvaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens.Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia.The SUCCESS model for laboratory performance and execution of rapid molecular diagnostics in patients with sepsis.The Confounding Role of Antimicrobial Stewardship Programs in Understanding the Impact of Technology on Patient Care.Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system.Impact of a rapid microarray-based assay for identification of positive blood cultures for treatment optimization for patients with streptococcal and enterococcal bacteremia.Performance evaluation of the Verigene® (Nanosphere) and FilmArray® (BioFire®) molecular assays for identification of causative organisms in bacterial bloodstream infections.Rapid identification of pathogens from pediatric blood cultures by use of the FilmArray blood culture identification panel.A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing with Direct Physician Response for Management of Staphyloccocus aureus Bacteremia.Sustained impact of a rapid microarray-based assay with antimicrobial stewardship interventions on optimizing therapy in patients with Gram-positive bacteraemia.Evaluation of the nanosphere Verigene BC-GN assay for direct identification of gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions.Antibiotic utilization improvement with the Nanosphere Verigene Gram-Positive Blood Culture assay.Syndromic Panel-Based Testing in Clinical Microbiology.Disease-based antimicrobial stewardship: a review of active and passive approaches to patient management.Diagnostic Stewardship for Healthcare-Associated Infections: Opportunities and Challenges to Safely Reduce Test Use.Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next.Culture-free bacterial detection and identification from blood with rapid, phenotypic, antibiotic susceptibility testing.
P2860
Q28068503-7DD67284-C768-49C0-8958-5F61920D53AAQ28541991-C5BEBB92-B853-4269-8036-F2E6D5E03BDAQ35035691-DA5BA374-2C56-49CC-B17C-6C974F02DC9BQ35165032-0B2FF6F3-7B99-4211-A200-69FE1FCB96CFQ36112329-51CB4900-A608-4E03-A128-C1B8CC14909DQ36124261-0586FC41-28A4-430C-B946-7AE66C488EDFQ36173894-A43C2D0B-CDB4-4991-A616-DC835754638EQ36287903-B6CEB575-168E-456A-9830-4A0836C706C2Q36736038-B965312B-CB00-439D-B122-0C7C425BA850Q36837889-7E2102D1-DAFA-490F-9B5C-DCDA098B2930Q37040468-BD1E3743-33E5-43E1-B8D2-79D35832FC02Q38207545-7F31325B-5E76-49BC-BCE0-5B6004B2CF4EQ38254825-EC0DDD01-AB1D-43B0-AC87-2678E6422739Q38417636-E0E88233-128F-4E2D-BE06-ECDE72C9DBE8Q38578350-79C523E2-C01D-4CB5-B9EE-04CF0C8CEE63Q38737360-2AF1BA15-05BC-4656-8F3F-422B40CB8C02Q38966337-6C803D48-C067-4188-BE0E-6F6B01BB26A1Q38987232-A3C6086D-578E-4C6E-8432-F83801ACC6F0Q39274504-800DE354-9868-4B15-8230-1B5683C61046Q40236193-5370E57F-15B8-46CE-8D24-51DEFD0C3E53Q40274990-7EF03EE8-382F-4D1E-8FB5-561E139BD88AQ40667972-71739F43-D1FD-41C0-A414-D288DD76C59EQ41130559-C3358290-4F75-4081-8A61-2F8FCB6CFA84Q41173033-C9964566-8016-406E-A7DE-BDFA6805DF0EQ41384383-33465CB5-C961-4741-B9B5-47FD43B7CFA5Q41488631-99A5C1F5-27D8-4734-B383-1A99DE244B82Q41703078-355D899B-13D2-430C-96DD-F7A6D65562D3Q41719296-75C42596-9F90-49D8-B123-B69D35522B4BQ41987244-A2E44620-340A-4723-B31F-87C2ECFDA982Q41992934-03721635-DB1F-43AB-9D5F-9F4DD09BDB3EQ42932575-729F9876-225F-428D-A1BC-CAEC8C7209D0Q43192965-DDB82A87-7A4D-4240-BB20-02C80E541A81Q47710544-EAABE8D3-91F3-4A71-B4EB-82B8D6FB79FAQ49609584-9F1D2BD1-7358-4719-A7A9-047A20E9B984Q50056481-7DCA58CA-29C8-4C29-9819-22CFF49A05C9Q50162071-357116CC-45C9-4CDA-96A6-14E45E3F9C89Q50325563-FFEF4A9B-031F-4D68-AA5C-B7541D8617BE
P2860
Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stewardship approach for optim ...... tive for Enterococcus species.
@en
Stewardship approach for optim ...... tive for Enterococcus species.
@nl
type
label
Stewardship approach for optim ...... tive for Enterococcus species.
@en
Stewardship approach for optim ...... tive for Enterococcus species.
@nl
prefLabel
Stewardship approach for optim ...... tive for Enterococcus species.
@en
Stewardship approach for optim ...... tive for Enterococcus species.
@nl
P2093
P2860
P356
P1476
Stewardship approach for optim ...... tive for Enterococcus species.
@en
P2093
Aaron Sango
Christopher A Jankowski
Donald Johnson
Jason Ferreira
Nilmarie Guzman
Yvette S McCarter
P2860
P304
P356
10.1128/JCM.01951-13
P407
P577
2013-09-25T00:00:00Z